<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0A9C75D5-8611-4897-B490-95CFAA3AC4E6"><gtr:id>0A9C75D5-8611-4897-B490-95CFAA3AC4E6</gtr:id><gtr:name>Anti-Doping Laboratory Qatar</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2E1EE4F0-1362-4767-A0D7-F7DA59F5F36D"><gtr:id>2E1EE4F0-1362-4767-A0D7-F7DA59F5F36D</gtr:id><gtr:name>Spanish Network Centre for Mastocytosis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4B3C1E93-5B2A-48D6-B874-887648D1FE3A"><gtr:id>4B3C1E93-5B2A-48D6-B874-887648D1FE3A</gtr:id><gtr:name>University of Paris XII: Paris-Val-de-Marne</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0B948AB1-85AA-4D27-939E-0D97737272F1"><gtr:id>0B948AB1-85AA-4D27-939E-0D97737272F1</gtr:id><gtr:name>Natural Environment Research Council</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FDF79F02-D617-4B22-9AB5-29364A8926A1"><gtr:id>FDF79F02-D617-4B22-9AB5-29364A8926A1</gtr:id><gtr:name>Suez Canal University</gtr:name><gtr:address><gtr:line1>El Salam District</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E7ABEDD8-C1C8-4A3B-8513-5993BB33921F"><gtr:id>E7ABEDD8-C1C8-4A3B-8513-5993BB33921F</gtr:id><gtr:name>Tanta University</gtr:name><gtr:address><gtr:line1>Sabarba</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F128C1F3-340C-4C0B-9BD0-93B2CEFF81BB"><gtr:id>F128C1F3-340C-4C0B-9BD0-93B2CEFF81BB</gtr:id><gtr:name>University of Paris Diderot (Paris 7)</gtr:name><gtr:address><gtr:line1>6th European PCRD</gtr:line1><gtr:line2>13 rue Pierre et Marie Curie</gtr:line2><gtr:postCode>F-75205</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7B9C2D48-4CEC-46B1-89E7-DE5DCD1FA320"><gtr:id>7B9C2D48-4CEC-46B1-89E7-DE5DCD1FA320</gtr:id><gtr:name>Borstel Research Centre</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D4ABA10F-2941-41AB-9B73-B6D4A4321752"><gtr:id>D4ABA10F-2941-41AB-9B73-B6D4A4321752</gtr:id><gtr:name>National Research Institute for Child Health and Development</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:department>Inflammation Infection and Repair</gtr:department><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0A9C75D5-8611-4897-B490-95CFAA3AC4E6"><gtr:id>0A9C75D5-8611-4897-B490-95CFAA3AC4E6</gtr:id><gtr:name>Anti-Doping Laboratory Qatar</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2E1EE4F0-1362-4767-A0D7-F7DA59F5F36D"><gtr:id>2E1EE4F0-1362-4767-A0D7-F7DA59F5F36D</gtr:id><gtr:name>Spanish Network Centre for Mastocytosis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4B3C1E93-5B2A-48D6-B874-887648D1FE3A"><gtr:id>4B3C1E93-5B2A-48D6-B874-887648D1FE3A</gtr:id><gtr:name>University of Paris XII: Paris-Val-de-Marne</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0B948AB1-85AA-4D27-939E-0D97737272F1"><gtr:id>0B948AB1-85AA-4D27-939E-0D97737272F1</gtr:id><gtr:name>Natural Environment Research Council</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FDF79F02-D617-4B22-9AB5-29364A8926A1"><gtr:id>FDF79F02-D617-4B22-9AB5-29364A8926A1</gtr:id><gtr:name>Suez Canal University</gtr:name><gtr:address><gtr:line1>El Salam District</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E7ABEDD8-C1C8-4A3B-8513-5993BB33921F"><gtr:id>E7ABEDD8-C1C8-4A3B-8513-5993BB33921F</gtr:id><gtr:name>Tanta University</gtr:name><gtr:address><gtr:line1>Sabarba</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F128C1F3-340C-4C0B-9BD0-93B2CEFF81BB"><gtr:id>F128C1F3-340C-4C0B-9BD0-93B2CEFF81BB</gtr:id><gtr:name>University of Paris Diderot (Paris 7)</gtr:name><gtr:address><gtr:line1>6th European PCRD</gtr:line1><gtr:line2>13 rue Pierre et Marie Curie</gtr:line2><gtr:postCode>F-75205</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7B9C2D48-4CEC-46B1-89E7-DE5DCD1FA320"><gtr:id>7B9C2D48-4CEC-46B1-89E7-DE5DCD1FA320</gtr:id><gtr:name>Borstel Research Centre</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D4ABA10F-2941-41AB-9B73-B6D4A4321752"><gtr:id>D4ABA10F-2941-41AB-9B73-B6D4A4321752</gtr:id><gtr:name>National Research Institute for Child Health and Development</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A5F4C021-35BD-4430-96EB-B7EF0E0EB175"><gtr:id>A5F4C021-35BD-4430-96EB-B7EF0E0EB175</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>Finlay</gtr:otherNames><gtr:surname>Walls</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C9E10D02-E579-4534-98A7-C9DDBBA115B3"><gtr:id>C9E10D02-E579-4534-98A7-C9DDBBA115B3</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Holloway</gtr:surname><gtr:orcidId>0000-0001-9998-0464</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500729"><gtr:id>A3D570F8-64F6-4649-9031-CFDE77A573D0</gtr:id><gtr:title>Variants of mast cell tryptase as markers and mediators of inflammation and tissue remodelling in asthma</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500729</gtr:grantReference><gtr:abstractText>Asthma and other allergic diseases represent a major health problem in this country. These conditions are associated with the release into the lungs of substantial quantities of an enzyme called tryptase. This has become a new target for drug development. 
There are multiple forms of tryptase, prominent among which are the alpha and beta forms. We propose to investigate the degree to which asthmatic patients may exhibit genetic differences in the tryptases they possess. The relatively little studied alpha tryptase will be purified and its properties compared with those of beta tryptase. 
The pattern of release of tryptases from cells will be studied, and the extent to which they are released into blood or fluids lining the lung examined. We shall carefully investigate the ability of the different tryptases to alter the function of cells to promote inflammation and structural alterations in the lung. These studies should advance understanding of fundamental processes of allergic disease and on the new approaches to treatment directed against tryptases.</gtr:abstractText><gtr:technicalSummary>Tryptase, the major product of human mast cells, is emerging as a key mediator of inflammation and tissue remodelling in asthma and other allergic conditions. This tetrameric serine protease is often considered as a single enzyme, but multiple sequences have been derived, and a family of related proteases mapped to chromosome 16p13.3. We shall investigate the degree of genetic variation at this site in families with bronchial asthma, and examine the potential for linkage with features of disease. Alpha tryptase will be purified from a recombinant expression system and enzymatic properties investigated with synthetic and natural substrates. Comparison will be made with the more extensively studied beta tryptases, and the degree to which heterotypic tetramers may form will be examined. The cellular expression and release will be examined of alpha and beta of tryptase in vitro, and in vivo in body fluids from patients with allergic conditions. The ability of alpha tryptase to stimulate altered gene expression in epithelial cells and airway smooth muscle cells will be investigated using microarray procedures, and compared with the patterns with beta tryptase. The release of selected cytokines, matrix components or mediators, and the rate of cell proliferation in response to alpha and beta tryptases will be investigated, exploring potential proteolytic and non-proteolytic mechanisms. The abilities of alpha tryptase to provoke pro-inflammatory changes following transfer to a guinea pig model will be assessed and compared with those of beta tryptase. This integrative biology approach should yield crucial information on the mediator actions of human tryptases and their potential as targets for therapeutic intervention.</gtr:technicalSummary><gtr:fund><gtr:end>2009-11-23</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-24</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>144940</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Spanish Network Centre for Mastocytosis</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Luis Escribano</gtr:description><gtr:id>A910F4E0-FC48-4985-8CCB-B3C2F98C1F89</gtr:id><gtr:impact>publications</gtr:impact><gtr:outcomeId>DApg3iccJg8-1</gtr:outcomeId><gtr:partnerContribution>Provision of samples from well characterised cases of mastocytosis.</gtr:partnerContribution><gtr:piContribution>Development of improved methods for diagnosis and clinical modelling of mastocytosis.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Borstel Research Centre</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Helmut Haas</gtr:description><gtr:id>0B740D05-D276-426B-A315-9EA257AF773B</gtr:id><gtr:impact>Studies conducted included in a PhD thesis
Publication pending</gtr:impact><gtr:outcomeId>evB51tc4W2S-2</gtr:outcomeId><gtr:partnerContribution>Provided training in new molecular biology procedures</gtr:partnerContribution><gtr:piContribution>Graduate student from our lab conducted studies in the partner laboratories using reagents prepared by our group</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Anti-Doping Laboratory Qatar</gtr:collaboratingOrganisation><gtr:country>Qatar, State of</gtr:country><gtr:description>Sayed Goda</gtr:description><gtr:id>5F498009-464A-4096-922D-280B8203E2A6</gtr:id><gtr:impact>Grant award.
Presentations at national and international meetings</gtr:impact><gtr:outcomeId>bc32nrfu9G8-1</gtr:outcomeId><gtr:partnerContribution>Provision of staff to work in our laboratory
Provision of materials from their institution</gtr:partnerContribution><gtr:piContribution>Supervision of research fellow and three research assistants. Set up a split site graduate student programme.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Borstel Research Centre</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Helmut Haas</gtr:description><gtr:id>7A5D12EF-123C-411B-8D8A-0C0F7DE5D9DF</gtr:id><gtr:impact>Studies conducted included in a PhD thesis
Publication pending</gtr:impact><gtr:outcomeId>evB51tc4W2S-1</gtr:outcomeId><gtr:partnerContribution>Provided training in new molecular biology procedures</gtr:partnerContribution><gtr:piContribution>Graduate student from our lab conducted studies in the partner laboratories using reagents prepared by our group</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Research Institute for Child Health and Development</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>Hirohisa Saito</gtr:description><gtr:id>3303776D-4B82-4FED-BE0F-C781BDDA0A4E</gtr:id><gtr:impact>Study presented at national meeting
Publication pending</gtr:impact><gtr:outcomeId>Pwx9NLn8cVe-1</gtr:outcomeId><gtr:partnerContribution>Graduate student worked in our laboratory for one year</gtr:partnerContribution><gtr:piContribution>Supervised a PhD student for a period of one year supported by his institution in Japan</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Natural Environment Research Council</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Ecology &amp; Hydrology (CEH)</gtr:department><gtr:description>Plant virus-induced alterations in the allergenicity of pollen</gtr:description><gtr:id>27CA26FE-76C7-4383-A339-CEF525731AC0</gtr:id><gtr:impact>Grant funding from two separate NERC-led initiatives. Research paper published</gtr:impact><gtr:outcomeId>513A6FDFBEE-1</gtr:outcomeId><gtr:partnerContribution>Provision of research materials, and useful discussions</gtr:partnerContribution><gtr:piContribution>Access to data and intellectual input into collaborator's research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tanta University</gtr:collaboratingOrganisation><gtr:country>Egypt, Arab Republic of</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Ahmed Abdelmotelb</gtr:description><gtr:id>26D29816-AFE8-415A-BEF4-8C8B0D8DEC60</gtr:id><gtr:impact>Successful completion of PhD course
Publications pending</gtr:impact><gtr:outcomeId>eQkFGkmFK6k-1</gtr:outcomeId><gtr:partnerContribution>Provided PhD student for 4 years</gtr:partnerContribution><gtr:piContribution>Provided training for PhD student over four years, and subsequently supervised as a research fellow</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Natural Environment Research Council</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Ecology &amp; Hydrology (CEH)</gtr:department><gtr:description>Novel inhibitors of tryptase as anti-allergic agents</gtr:description><gtr:id>0576D2D3-F024-4FFE-8D26-28E123892585</gtr:id><gtr:impact>Grant funding from NERC</gtr:impact><gtr:outcomeId>FD4A465A21B-1</gtr:outcomeId><gtr:partnerContribution>Provision of novel reagents</gtr:partnerContribution><gtr:piContribution>Access to data and intellectual input into collaborator's research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Paris XII: Paris-Val-de-Marne</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Chaza Mecheri</gtr:description><gtr:id>B57E0555-1601-4256-837C-3EE6A7D444CD</gtr:id><gtr:impact>publication pending</gtr:impact><gtr:outcomeId>PcahCdPmG9n-1</gtr:outcomeId><gtr:partnerContribution>training of student in research practice</gtr:partnerContribution><gtr:piContribution>training in cell culture, studies with mast cell proteases</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Paris Diderot University</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Uli Blank</gtr:description><gtr:id>A49B5F5D-5EE5-4F2F-AFC3-79901E20E780</gtr:id><gtr:impact>New information on fundamental processes in kidney disease</gtr:impact><gtr:outcomeId>bvetwDrWVRC-1</gtr:outcomeId><gtr:partnerContribution>training in techniques of kidney cell culture</gtr:partnerContribution><gtr:piContribution>training in techniques related to calcium flux and provision of laboratory facilities</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Suez Canal University</gtr:collaboratingOrganisation><gtr:country>Egypt, Arab Republic of</gtr:country><gtr:department>Faculty of Pharmacy</gtr:department><gtr:description>Mogib Khedr</gtr:description><gtr:id>E51BBA5F-E69A-4C00-86D2-814982BB468B</gtr:id><gtr:impact>Successful completion of PhD course
Publications pending</gtr:impact><gtr:outcomeId>Wd62kHgXQLk-1</gtr:outcomeId><gtr:partnerContribution>Provided a PhD student for 4 years</gtr:partnerContribution><gtr:piContribution>Provided training for a PhD student over 4 years</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Support to mastocytosis patients' support group - York</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>45D8EF77-8B3B-46AA-B4DE-9E8F02626AD7</gtr:id><gtr:impact>As a researcher in the mast cell field I was approached to give a talk at a meeting which led to the foundation of a support group for mastocytosis suffers in the UK (first national meeting was in York). There has been frequent contact since then and I have advised subsequently on aspects of the condition, on research in the field, etc.

The group is growing in size and in influence, and is now exploring setting up a research charity.</gtr:impact><gtr:outcomeId>337507496F0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>244408</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>New and Emerging Applications of Technology Programme NEAT H039 Development of discriminating tests for allergic reactions to medicines and anaesthetics, based on the assay of unique products of mast cell and basophil activation</gtr:description><gtr:end>2010-07-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>0D288E02-BFF1-4BB1-9578-9AE2EADB5072</gtr:id><gtr:outcomeId>949BBD6C0C00</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>European Union Cooperation in Science and Technology COST scheme</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>9D5EB494-50C4-4F5F-9FF9-12D253C7E58A</gtr:id><gtr:outcomeId>Fj5u8jwfgKm</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>FSA, Studentship</gtr:description><gtr:end>2010-11-02</gtr:end><gtr:fundingOrg>Food Standards Agency (FSA)</gtr:fundingOrg><gtr:id>848E4CF4-A648-445B-B686-5CB0992C7DC8</gtr:id><gtr:outcomeId>F7755B106F90</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Institute for Life Sciences/Faculty Studentship</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>University of Southampton</gtr:fundingOrg><gtr:id>0F43438A-1EB1-45C8-AF0B-12CA480961F3</gtr:id><gtr:outcomeId>5464c4584ecec3.54490248</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>148000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Asthma UK Project Grant</gtr:description><gtr:end>2009-11-02</gtr:end><gtr:fundingOrg>Asthma UK</gtr:fundingOrg><gtr:id>81009C4D-C6E1-49CA-96B2-90CBE83A6431</gtr:id><gtr:outcomeId>6713F30D86E0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>Jersey, Bailiwick of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wessex Medical Trust, States of Jersey Research Grant</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>States of Jersey</gtr:fundingOrg><gtr:id>EA99F761-3DC8-4DEB-80C9-59AEF2A677A1</gtr:id><gtr:outcomeId>243F08C86CF0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Lullaby Trust Project grant</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>The Lullaby Trust</gtr:fundingOrg><gtr:id>A4BA223E-A0B4-4E65-B6F0-044CDCF371C7</gtr:id><gtr:outcomeId>QwxLJMxK8fy</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>930000</gtr:amountPounds><gtr:country>Qatar, State of</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:department>Qatar National Research Fund</gtr:department><gtr:description>National Research Priority Funding</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Qatar Foundation</gtr:fundingOrg><gtr:id>D2E5A94C-46CF-4372-BAAA-0905256512B5</gtr:id><gtr:outcomeId>VphZrZfY48Z</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>18000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Impact Acceleration Account</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Natural Environment Research Council</gtr:fundingOrg><gtr:id>556E545D-0C91-401A-BB4E-3DF5B90611AE</gtr:id><gtr:outcomeId>J1gnvurGmcQ</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>86259</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Comprehensive Clinical Research Network (Coordinating Centre) ? NIHR</gtr:department><gtr:description>Flexibility and Sustainability Funding (FSF)</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>002958A0-FA8F-42B0-A533-2AF91ED8923C</gtr:id><gtr:outcomeId>QRXwnos9qmp</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Educational grant</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Novartis</gtr:fundingOrg><gtr:id>7E4609C6-CCB0-4917-A1FF-AD08993660F1</gtr:id><gtr:outcomeId>5464c3a2d24312.46861599</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Santander Internationalisation Fund</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Santander Universities</gtr:fundingOrg><gtr:id>8A25A736-E2AD-49C4-A12D-C384EB78911C</gtr:id><gtr:outcomeId>LkUd4ehnVZK</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>21000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Part funded studentship</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>University of Southampton</gtr:fundingOrg><gtr:id>177B000A-6EC7-4160-AD6B-00E4D8DA57FF</gtr:id><gtr:outcomeId>5464c30c3109d4.31342666</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8937</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research grant</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Asthma Allergy &amp; Inflammation Research (AAIR)</gtr:fundingOrg><gtr:id>F49B65EA-BAAC-4F6E-AC3C-456AAB4A1EB5</gtr:id><gtr:outcomeId>58c9554f54bd93.76498692</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60678</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NERC Environment and Human Health Programme NE/E009417/1 Plant virus infection as a determinant of pollen allergenicity</gtr:description><gtr:end>2010-06-02</gtr:end><gtr:fundingOrg>Natural Environment Research Council</gtr:fundingOrg><gtr:fundingRef>NE/E009417/1</gtr:fundingRef><gtr:id>EBC75AA2-BB4C-4698-9EF7-6A056E166BA5</gtr:id><gtr:outcomeId>976086F579E0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>70000</gtr:amountPounds><gtr:country>Nigeria, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Graduate studentship</gtr:description><gtr:end>2019-01-02</gtr:end><gtr:fundingOrg>Bayero University Kano</gtr:fundingOrg><gtr:id>D83E64E5-2090-4C67-9E18-0AB31814769A</gtr:id><gtr:outcomeId>5464c5f499c2f7.68753550</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Higher Education Innovation Funding</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Higher Education Funding Council for England (HEFCE)</gtr:fundingOrg><gtr:id>8671B87C-B3E5-41DB-B6B7-768760F8DF9D</gtr:id><gtr:outcomeId>5464c51a9d1382.03130100</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>81000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NERC Innovation Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Natural Environment Research Council</gtr:fundingOrg><gtr:id>133EC87F-830C-4F82-917C-C79CD69D982E</gtr:id><gtr:outcomeId>43F9CBA4B980</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>70000</gtr:amountPounds><gtr:country>Iraq, Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Graduate studentship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Iraqi Government</gtr:fundingOrg><gtr:id>7815FD0D-F22C-44CD-95E5-AE35B7751A8D</gtr:id><gtr:outcomeId>5464c58199cd93.15639011</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Risk factors for anaphylaxis</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>5B67F939-E638-4804-9C74-DADAFD1153A6</gtr:id><gtr:impact>Increases awareness of anaphylaxis as a clinically important condition</gtr:impact><gtr:outcomeId>E5E16EBDF6D</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Anaphylaxis provoked by anaesthetics</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>050EAB31-89C8-45CE-A3DB-54A7171AF76D</gtr:id><gtr:impact>The guidelines will encourage the routine collection of blood samples for the measurement of mast cell tryptase.</gtr:impact><gtr:outcomeId>23E493CE4D1</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Diagnostic assay</gtr:description><gtr:id>B7D7163C-F8AF-415E-BCE2-DBBB2F2F07CB</gtr:id><gtr:impact>Improved diagnosis</gtr:impact><gtr:outcomeId>Mx1PzedUfwW</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Assay for mast cell chymase</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>New monoclonal antibodies have been prepared and incorporated into new prototype assays for tryptase</gtr:description><gtr:id>DD2C5F87-A9E7-4B14-894E-E47FBE7660E7</gtr:id><gtr:impact>Production of new monoclonal antibodies against tryptases has led to development of better assays for these proteases.</gtr:impact><gtr:outcomeId>D36687C9886</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Improved assay for mast cell tryptases</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9F428999-9150-45C0-86B8-D4CACA9BC7F8</gtr:id><gtr:title>Basophils infiltrate the skin lesions in lepromatous leprosy.</gtr:title><gtr:parentPublicationTitle>Acta dermato-venereologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba26863e327a9f60d8b21b8e6133cd9e"><gtr:id>ba26863e327a9f60d8b21b8e6133cd9e</gtr:id><gtr:otherNames>Otsuka A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-5555</gtr:issn><gtr:outcomeId>pm_16614_24_22513483</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E04ABBB8-9C9E-407F-9775-BD5F893262F3</gtr:id><gtr:title>Proof of concept pilot study: prevalence of grass virus infection and the potential for effects on the allergenic potency of pollen.</gtr:title><gtr:parentPublicationTitle>Environmental health : a global access science source</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7179c436c95f8725d83ddbcbdfbe3bed"><gtr:id>7179c436c95f8725d83ddbcbdfbe3bed</gtr:id><gtr:otherNames>Pallett DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1476-069X</gtr:issn><gtr:outcomeId>6C0C4B52C9F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCE573E7-BDCD-45C0-8831-D6923979F1EB</gtr:id><gtr:title>CCR5 usage by CCL5 induces a selective leukocyte recruitment in human skin xenografts in vivo.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a856d51646d666cb74ffe18a6615433"><gtr:id>3a856d51646d666cb74ffe18a6615433</gtr:id><gtr:otherNames>de Nada? P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>26D6CB321AA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6CA2AAF-E390-41BA-8A2E-4C4051CF92A4</gtr:id><gtr:title>Multidimensional endotypes of asthma: topological data analysis of cross-sectional clinical, pathological, and immunological data.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a45d701f4ef5ee26a6abcbf67e73393"><gtr:id>7a45d701f4ef5ee26a6abcbf67e73393</gtr:id><gtr:otherNames>Hinks T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>56e05875a71705.74673134</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDE3F1AB-9BD5-4CA1-8F68-44F6DCA4A087</gtr:id><gtr:title>Hyperexpression of the high-affinity IgE receptor-beta chain in chronic allergic keratoconjunctivitis.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f9b2f7c91118cdc553f2af3ab354e27"><gtr:id>5f9b2f7c91118cdc553f2af3ab354e27</gtr:id><gtr:otherNames>Matsuda A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>9B1F9DC8B38</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DE240F9-D8B9-409F-8532-BDD7FA59F22A</gtr:id><gtr:title>Identification of mast cells and mast cell subpopulations.</gtr:title><gtr:parentPublicationTitle>Methods in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4d02786bffb6ca7c076755a291f45cd"><gtr:id>b4d02786bffb6ca7c076755a291f45cd</gtr:id><gtr:otherNames>Buckley M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1543-1894</gtr:issn><gtr:outcomeId>2FF6CB1482D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A3C8C26-479F-4F6D-8644-6C6B6897453C</gtr:id><gtr:title>Basophil infiltration in eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f6258c0d789976861f5aa0497f900eb"><gtr:id>6f6258c0d789976861f5aa0497f900eb</gtr:id><gtr:otherNames>Iwakura N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>56e05a02434168.96722229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D010A2D8-EF30-4494-9477-8E35B2A6D858</gtr:id><gtr:title>Comparison of basophil infiltration into the skin between eosinophilic pustular folliculitis and neutrophilic folliculitis.</gtr:title><gtr:parentPublicationTitle>Journal of the European Academy of Dermatology and Venereology : JEADV</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba26863e327a9f60d8b21b8e6133cd9e"><gtr:id>ba26863e327a9f60d8b21b8e6133cd9e</gtr:id><gtr:otherNames>Otsuka A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0926-9959</gtr:issn><gtr:outcomeId>K8wTAVzzhSo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E05F3F71-0BC3-435E-9DD8-D836F1743C6B</gtr:id><gtr:title>Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbe3e8c882592ae2f0173365f44d1ffc"><gtr:id>bbe3e8c882592ae2f0173365f44d1ffc</gtr:id><gtr:otherNames>Teodosio C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>keeNkTRNyVp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3671C0E-601B-4053-964F-A61AF9E9FB67</gtr:id><gtr:title>Effect of honey and its major royal jelly protein 1 on cytokine and MMP-9 mRNA transcripts in human keratinocytes.</gtr:title><gtr:parentPublicationTitle>Experimental dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ad3530f168f19ac46ec790521f17971"><gtr:id>5ad3530f168f19ac46ec790521f17971</gtr:id><gtr:otherNames>Majtan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0906-6705</gtr:issn><gtr:outcomeId>FCBF69588DC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AACCDE2-9A67-41A8-957D-B6002D5892BB</gtr:id><gtr:title>Desquamation of human coronary artery endothelium by human mast cell proteases: implications for plaque erosion.</gtr:title><gtr:parentPublicationTitle>Coronary artery disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3348d8620be829ead93c4e2ed5132677"><gtr:id>3348d8620be829ead93c4e2ed5132677</gtr:id><gtr:otherNames>M?yr?np?? MI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0954-6928</gtr:issn><gtr:outcomeId>344E9CAEECF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F95469C3-2D4E-4C35-B30F-9B43F99B2881</gtr:id><gtr:title>Identification of basogranulin (BB1) as a novel immunohistochemical marker of basophils in normal bone marrow and patients with myeloproliferative disorders.</gtr:title><gtr:parentPublicationTitle>American journal of clinical pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb5102e8af8efc29f885d751a284299c"><gtr:id>cb5102e8af8efc29f885d751a284299c</gtr:id><gtr:otherNames>Agis H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0002-9173</gtr:issn><gtr:outcomeId>F50DAB855B6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4902BB9-A8A7-4526-822C-7B0C61B5865A</gtr:id><gtr:title>Expression and functions of the vascular endothelial growth factors and their receptors in human basophils.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e776cd46814cf6fdc3fdd29b140f8fa"><gtr:id>1e776cd46814cf6fdc3fdd29b140f8fa</gtr:id><gtr:otherNames>de Paulis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>EE8412CB89D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D12B8407-0B29-4BDC-96F2-E4BD58900687</gtr:id><gtr:title>Purification and characterization of mast cell tryptase and chymase from human tissues.</gtr:title><gtr:parentPublicationTitle>Methods in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19ab40cb48930a589d40f074a589781d"><gtr:id>19ab40cb48930a589d40f074a589781d</gtr:id><gtr:otherNames>McEuen AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1543-1894</gtr:issn><gtr:outcomeId>357FFC5F088</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>005852DF-CFA9-4F68-914A-2000D07711BB</gtr:id><gtr:title>The role of the mast cell in the pathophysiology of asthma.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92cfa67a6e199ac9c8e6c92412e8247d"><gtr:id>92cfa67a6e199ac9c8e6c92412e8247d</gtr:id><gtr:otherNames>Bradding P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>A4CEF5904A6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F99D6F2D-D385-4E45-B2AD-40D9D0EB36EE</gtr:id><gtr:title>Alpha-tryptase gene variation is associated with levels of circulating IgE and lung function in asthma.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5559456de6eebb832a681abf4df47951"><gtr:id>5559456de6eebb832a681abf4df47951</gtr:id><gtr:otherNames>Abdelmotelb AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>pm_540e141e141015187</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>405C3A5C-4993-4576-BCBB-678F8B5ECF90</gtr:id><gtr:title>A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D).</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad06e47565ab8af23092fda896f53818"><gtr:id>ad06e47565ab8af23092fda896f53818</gtr:id><gtr:otherNames>Lam C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>56e05981e816e9.37444925</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75E59E23-77FA-4DAA-B6E9-FABD044301E6</gtr:id><gtr:title>Basophil recruitment and activation in inflammatory skin diseases.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64923cae2c072a74b56d91891a70964b"><gtr:id>64923cae2c072a74b56d91891a70964b</gtr:id><gtr:otherNames>Ito Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>bNRpocYrWbQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17EF1CDB-C19D-4A77-BD4B-51BDBD4A63C2</gtr:id><gtr:title>Neutrophilia, gelatinase release and microvascular leakage induced by human mast cell tryptase in a mouse model: Lack of a role of protease activated receptor 2 (PAR2).</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2327edc26c158da357c09c30afbe6b8b"><gtr:id>2327edc26c158da357c09c30afbe6b8b</gtr:id><gtr:otherNames>Khedr MMS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>5aa919bd822df2.43572263</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EFDE040-DA00-40CE-A2C0-A49921EB5BF9</gtr:id><gtr:title>Risk assessment in anaphylaxis: current and future approaches.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/266cfbf004dec3f164fb520876d3431d"><gtr:id>266cfbf004dec3f164fb520876d3431d</gtr:id><gtr:otherNames>Simons FE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>3166770B84E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BE2F74F-CFC7-4D3A-A7B9-0BF06F1974A3</gtr:id><gtr:title>Basophils in the giant papillae of chronic allergic keratoconjunctivitis.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f9b2f7c91118cdc553f2af3ab354e27"><gtr:id>5f9b2f7c91118cdc553f2af3ab354e27</gtr:id><gtr:otherNames>Matsuda A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>537397BC8AD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACDEFFE7-772B-4EB3-BFB8-914ED9F23E1E</gtr:id><gtr:title>Alveolar T-helper type-2 immunity in atopic asthma is associated with poor clinical control.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7c9964b55b4155fc8cde8cf1a53d498"><gtr:id>d7c9964b55b4155fc8cde8cf1a53d498</gtr:id><gtr:otherNames>Bergqvist A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn><gtr:outcomeId>5464b8bb26a692.12965072</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>679D28D3-E218-4490-8A8E-920A99BBC76F</gtr:id><gtr:title>The regulatory role of Dipeptidyl peptidase I on the activation of immune granulocytes.</gtr:title><gtr:parentPublicationTitle>Cell biology international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d4d462a28e1603805e07de64aed7b6f"><gtr:id>5d4d462a28e1603805e07de64aed7b6f</gtr:id><gtr:otherNames>Chu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1065-6995</gtr:issn><gtr:outcomeId>5aa919be093970.89396633</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33AE273F-1F6F-4553-BBC0-AE3D869959E5</gtr:id><gtr:title>Altered Expression of Brain Proteinase-Activated Receptor-2, Trypsin-2 and Serpin Proteinase Inhibitors in Parkinson's Disease.</gtr:title><gtr:parentPublicationTitle>Journal of molecular neuroscience : MN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74e3e1df9060c990deb955df296ef98c"><gtr:id>74e3e1df9060c990deb955df296ef98c</gtr:id><gtr:otherNames>Hurley MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0895-8696</gtr:issn><gtr:outcomeId>56e058e5ede788.65426473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42620A2C-DE86-44B4-9E77-F9BDC6E6A29D</gtr:id><gtr:title>Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): a multicentre, parallel-group, randomised placebo-controlled trial</gtr:title><gtr:parentPublicationTitle>Efficacy and Mechanism Evaluation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad06e47565ab8af23092fda896f53818"><gtr:id>ad06e47565ab8af23092fda896f53818</gtr:id><gtr:otherNames>Lam C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56e05b3562f3e4.20709750</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3A4DA97-5358-4619-83C3-5D05D96B96C7</gtr:id><gtr:title>Practical allergy (PRACTALL) report: risk assessment in anaphylaxis.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/266cfbf004dec3f164fb520876d3431d"><gtr:id>266cfbf004dec3f164fb520876d3431d</gtr:id><gtr:otherNames>Simons FE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>29195D80D2B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A08CD76C-89D3-4603-89F4-6F0C9DBFFBCD</gtr:id><gtr:title>Repeated Amblyomma testudinarium tick bites are associated with increased galactose-a-1,3-galactose carbohydrate IgE antibody levels: A retrospective cohort study in a single institution.</gtr:title><gtr:parentPublicationTitle>Journal of the American Academy of Dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cfefadf9f8cea903c1110e9d5ab90ed"><gtr:id>0cfefadf9f8cea903c1110e9d5ab90ed</gtr:id><gtr:otherNames>Hashizume H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0190-9622</gtr:issn><gtr:outcomeId>5aa919bdc2c064.91750246</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A1D6B3E-F3DE-4F3C-A1BE-1D4F39E0D71E</gtr:id><gtr:title>Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/120396197daed2aafc88b77aa88f1912"><gtr:id>120396197daed2aafc88b77aa88f1912</gtr:id><gtr:otherNames>Hinks TS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>5675e07b45d0a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78818FF9-DFAF-4C7B-BC49-02FCF2CC9C11</gtr:id><gtr:title>Suspected anaphylactic reactions associated with anaesthesia.</gtr:title><gtr:parentPublicationTitle>Anaesthesia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/958964d1e3d5437b123e4daeb28d0201"><gtr:id>958964d1e3d5437b123e4daeb28d0201</gtr:id><gtr:otherNames>Harper NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0003-2409</gtr:issn><gtr:outcomeId>A8D4E28827B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>490EE97B-9706-40D4-8E61-A5D43F86FE40</gtr:id><gtr:title>Experimental activation of mast cells and their pharmacological modulation.</gtr:title><gtr:parentPublicationTitle>Methods in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6768cacf3239c48762109dc1b6fede50"><gtr:id>6768cacf3239c48762109dc1b6fede50</gtr:id><gtr:otherNames>He S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1543-1894</gtr:issn><gtr:outcomeId>2921C0090FF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7253EEEA-7CEC-4450-B8BC-8C99BADE6364</gtr:id><gtr:title>Up-regulation of protease-activated receptor-2 by bFGF in cultured human synovial fibroblasts.</gtr:title><gtr:parentPublicationTitle>Life sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55d8be9e87347fe716b18375089894a4"><gtr:id>55d8be9e87347fe716b18375089894a4</gtr:id><gtr:otherNames>Abe K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0024-3205</gtr:issn><gtr:outcomeId>199276BCC18</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F650431-B53A-4691-BD1D-9A62134B3BD7</gtr:id><gtr:title>Detection of mast cells and basophils by immunohistochemistry.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e719e40054355fb8442d113845ddf0a5"><gtr:id>e719e40054355fb8442d113845ddf0a5</gtr:id><gtr:otherNames>Walls AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>5464b8bb60df29.82224940</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>083277EF-D7B9-4342-A93C-B3235A0B618D</gtr:id><gtr:title>Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases.</gtr:title><gtr:parentPublicationTitle>The World Allergy Organization journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d906766600c11262712ceebae9841ee0"><gtr:id>d906766600c11262712ceebae9841ee0</gtr:id><gtr:otherNames>Metcalfe DD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1939-4551</gtr:issn><gtr:outcomeId>56e0582648fb84.72624204</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB96A099-626D-4609-8CD7-4D5F9CD876B3</gtr:id><gtr:title>NADPH oxidase-independent formation of extracellular DNA traps by basophils.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cfaf267a92af8e2ae49789ce809ba74"><gtr:id>1cfaf267a92af8e2ae49789ce809ba74</gtr:id><gtr:otherNames>Morshed M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5464b8bb8c1770.63613508</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D3C8DA8-908E-4FB2-BBA9-117E556854DD</gtr:id><gtr:title>Discriminating between the activities of human cathepsin G and chymase using fluorogenic substrates.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10f05821cfd3c45d2d1ba3f10a448e6c"><gtr:id>10f05821cfd3c45d2d1ba3f10a448e6c</gtr:id><gtr:otherNames>Korkmaz B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>ZbntQjhmsBY</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500729</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>